The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Hetrazan     N,N-diethyl-4-methyl- piperazine-1-carboxamide

Synonyms: Banocide, Caracide, Caricide, Decacide, Ethodryl, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Carbamazine

 

High impact information on Carbamazine

 

Chemical compound and disease context of Carbamazine

 

Biological context of Carbamazine

 

Anatomical context of Carbamazine

 

Associations of Carbamazine with other chemical compounds

 

Gene context of Carbamazine

 

Analytical, diagnostic and therapeutic context of Carbamazine

References

  1. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. Greene, B.M., Taylor, H.R., Cupp, E.W., Murphy, R.P., White, A.T., Aziz, M.A., Schulz-Key, H., D'Anna, S.A., Newland, H.S., Goldschmidt, L.P. N. Engl. J. Med. (1985) [Pubmed]
  2. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. Ottesen, E.A., Vijayasekaran, V., Kumaraswami, V., Perumal Pillai, S.V., Sadanandam, A., Frederick, S., Prabhakar, R., Tripathy, S.P. N. Engl. J. Med. (1990) [Pubmed]
  3. Diethylcarbamazine and human loiasis. Jaccard, A., Lortholary, O., Visser, H. N. Engl. J. Med. (1989) [Pubmed]
  4. Platelets mediate the action of diethylcarbamazine on microfilariae. Cesbron, J.Y., Capron, A., Vargaftig, B.B., Lagarde, M., Pincemail, J., Braquet, P., Taelman, H., Joseph, M. Nature (1987) [Pubmed]
  5. Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. Limaye, A.P., Abrams, J.S., Silver, J.E., Awadzi, K., Francis, H.F., Ottesen, E.A., Nutman, T.B. J. Clin. Invest. (1991) [Pubmed]
  6. Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy. Pinkston, P., Vijayan, V.K., Nutman, T.B., Rom, W.N., O'Donnell, K.M., Cornelius, M.J., Kumaraswami, V., Ferrans, V.J., Takemura, T., Yenokida, G. J. Clin. Invest. (1987) [Pubmed]
  7. Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. Kenzora, J.L., Pérez, J.E., Bergmann, S.R., Lange, L.G. J. Clin. Invest. (1984) [Pubmed]
  8. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Abiose, A., Jones, B.R., Cousens, S.N., Murdoch, I., Cassels-Brown, A., Babalola, O.E., Alexander, N.D., Nuhu, I., Evans, J., Ibrahim, U.F. Lancet (1993) [Pubmed]
  9. Proteinuria associated with diethylcarbamazine. Ngu, J.L., Mate, A., Leke, R., Titanji, V. Lancet (1980) [Pubmed]
  10. Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. Dominguez-Vazquez, A., Taylor, H.R., Greene, B.M., Ruvalcaba-Macias, A.M., Rivas-Alcala, A.R., Murphy, R.P., Beltran-Hernandez, F. Lancet (1983) [Pubmed]
  11. Cardiovascular effects of leukotrienes in neonatal piglets. Role in hypoxic pulmonary vasoconstriction? Leffler, C.W., Mitchell, J.A., Green, R.S. Circ. Res. (1984) [Pubmed]
  12. Albendazole therapy for loiasis refractory to diethylcarbamazine treatment. Klion, A.D., Horton, J., Nutman, T.B. Clin. Infect. Dis. (1999) [Pubmed]
  13. Passive paw anaphylaxis in the rat. Optimum conditions for use in studies on immediate hypersensitivity. Baldo, B.A., Thomas, P.G., Nelson, C.L., Taylor, K.M. Allergy (1980) [Pubmed]
  14. Antibodies to phosphocholine-bearing antigens in lymphatic filariasis and changes following treatment with diethylcarbamazine. Lal, R.B., Ottesen, E.A. Clin. Exp. Immunol. (1989) [Pubmed]
  15. Novel inhibition of proteoglycan synthesis and exocytosis by diethylcarbamazine in the Swarm rat chondrocyte. Stevens, R.L., Parsons, W.G., Austen, K.F., Hein, A., Caulfield, J.P. J. Biol. Chem. (1985) [Pubmed]
  16. Aggregation of equine platelets by Onchocerca cervicalis collagen. McConnell, L.A., Leid, R.W. Am. J. Pathol. (1983) [Pubmed]
  17. Limb ischemia-induced increase in permeability is mediated by leukocytes and leukotrienes. Klausner, J.M., Paterson, I.S., Valeri, C.R., Shepro, D., Hechtman, H.B. Ann. Surg. (1988) [Pubmed]
  18. Effect of sodium nitroprusside and diethylcarbamazine on hypoxic pulmonary vasoconstriction and regional distribution of pulmonary blood flow in experimental pneumonia. Light, R.B. Am. J. Respir. Crit. Care Med. (1996) [Pubmed]
  19. Changes in antibody profile after treatment of human onchocerciasis. Lee, S.J., Francis, H.L., Awadzi, K., Ottesen, E.A., Nutman, T.B. J. Infect. Dis. (1990) [Pubmed]
  20. Hypoxia provokes leukotriene-dependent neutrophil sequestration in perfused rabbit hearts. Gillespie, M.N., Kojima, S., Owasoyo, J.O., Tai, H.H., Jay, M. J. Pharmacol. Exp. Ther. (1987) [Pubmed]
  21. The influence of arachidonic acid metabolites on leukocyte activation and skeletal muscle injury after ischemia and reperfusion. Cambria, R.A., Anderson, R.J., Dikdan, G., Lysz, T.W., Hobson, R.W. J. Vasc. Surg. (1991) [Pubmed]
  22. Diethylcarbamazine, antifilarial drug, inhibits microtubule polymerization and disrupts preformed microtubules. Fujimaki, Y., Ehara, M., Kimura, E., Shimada, M., Aoki, Y. Biochem. Pharmacol. (1990) [Pubmed]
  23. Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor. Bach, M.K., Brashler, J.R. Biochem. Pharmacol. (1986) [Pubmed]
  24. Cardiac injury by activated leukocytes: effect of cyclooxygenase and lipoxygenase inhibition evaluated by electron microscopical morphometry. Semb, A.G., Ytrehus, K., Vaage, J., Myklebust, R. J. Mol. Cell. Cardiol. (1996) [Pubmed]
  25. Inhibitory effects of various drugs on dual asthmatic responses in wheat flour-sensitive subjects. Nakazawa, T., Toyoda, T., Furukawa, M., Taya, T., Kobayashi, S. J. Allergy Clin. Immunol. (1976) [Pubmed]
  26. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Lechner, A.J., Velasquez, A., Knudsen, K.R., Johanns, C.A., Tracy, T.F., Matuschak, G.M. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
  27. Effects of various pharmacologic agents on allergic inflammation of the eye. The roles of chemical mediators in ocular inflammation. Okada, M., Shimada, K. Invest. Ophthalmol. Vis. Sci. (1980) [Pubmed]
  28. Positive end-expiratory pressure-induced, calcium-channel-mediated increases in pulmonary vascular resistance in neonatal lambs. Venkataraman, S.T., Fuhrman, B.P., Howland, D.F., DeFrancisis, M. Crit. Care Med. (1993) [Pubmed]
  29. Antioxidant enzymes in Acanthocheilonema viteae and effect of antifilarial agents. Batra, S., Chatterjee, R.K., Srivastava, V.M. Biochem. Pharmacol. (1990) [Pubmed]
  30. Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine. Pearlman, E., Toé, L., Boatin, B.A., Gilles, A.A., Higgins, A.W., Unnasch, T.R. J. Infect. Dis. (1999) [Pubmed]
  31. Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis. Turner, P.F., Rockett, K.A., Ottesen, E.A., Francis, H., Awadzi, K., Clark, I.A. J. Infect. Dis. (1994) [Pubmed]
  32. Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery. Jovanović, A., Jovanović, S., Tulić, I., Grbović, L. Mol. Hum. Reprod. (1998) [Pubmed]
  33. Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway. McGarry, H.F., Plant, L.D., Taylor, M.J. Filaria journal [electronic resource]. (2005) [Pubmed]
  34. Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study. Nutman, T.B., Miller, K.D., Mulligan, M., Reinhardt, G.N., Currie, B.J., Steel, C., Ottesen, E.A. N. Engl. J. Med. (1988) [Pubmed]
  35. Inhibition of lipoxygenase and cyclooxygenase augments cardiac injury by H2O2. Valen, G., Semb, A.G., Vaage, J. Free Radic. Biol. Med. (1993) [Pubmed]
  36. The immunodominant Brugia malayi paramyosin as a marker of current infection with Wuchereria bancrofti adult worms. Langy, S., Plichart, C., Luquiaud, P., Williams, S.A., Nicolas, L. Infect. Immun. (1998) [Pubmed]
  37. Studies of immediate hypersensitivity in a patient with Acanthocheilonema perstans filarial infection. Rubin, R.H., Austen, K.F., Goetzl, E.J. J. Infect. Dis. (1975) [Pubmed]
 
WikiGenes - Universities